[ad_1]
Updated:
-
ofMomir takac
conclude
As one of nine pharmaceutical companies worldwide, AstraZeneca is in the crucial testing phase for a corona vaccine. But the study must be discontinued.
- AstraZeneca is considered a great hope for the development of a Corona vaccine.
- But now the Swedish-British pharmaceutical company has to stop the clinical trial phase.
- Here you will find the basic facts about the coronavirus * and the news about the corona from Germany. We also offer you the current number of cases in Germany on a map.
Munich: people around the world want you vaccine to be able to fight the corona pandemic * effectively. A company is well advanced in the development of a serum. The British-Swedish pharmaceutical company AstraZeneca It is one of nine corporations worldwide in the third and final phase of clinical studies and is considered a great hope. Tests were being conducted with tens of thousands of participants.
Corona vaccine: AstraZeneca has to interrupt the testing phase
But in the race for vaccine approval * you must AstraZeneca Now accept a big setback. Because a test person has had health problems, the clinic stopped for the moment. This is a routine measure “that should be carried out whenever a potentially unexplained illness occurs in any of the studies,” a company spokesman said.
It went on to say that the process had been voluntarily interrupted “to allow an independent committee to verify the safety data.”
Tests for corona vaccine interrupted: patient is said to have a rare neurological disease
What disease is it and where is the patient, had to AstraZeneca No information. But there are speculations and rumors. the New York Times wants to know from an informed person who is said to have transverse myelitis. This is a rare neurological disorder caused by inflammation of the central nervous system caused by viruses.
Breaking news: A major coronavirus vaccine trial was halted due to a serious adverse reaction in a participant, the pharmaceutical company AstraZeneca said. https://t.co/PC4EYqPr1c
– The New York Times (@nytimes) September 8, 2020
The one of AstraZeneca The active ingredient AZD1222 is based on the weakened version of a chimpanzee cold virus and is supposed to activate the immune system so that it can fight Sars-CoV-2 * in case of infection. (mt / dpa) * Merkur.de is part of the Ippen digital publishing network nationwide.
Headline list image: © Ted S. Warren / dpa
[ad_2]
